Prevention program for adults at risk of OCD
The Efficacy of an OCD Prevention Programme for at Risk Adults: a Randomized Clinical Trial
This study is testing a two-week program to see if it can help adults at risk of developing OCD feel better compared to those who just get regular treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Babes-Bolyai University Academic / other |
| Locations | 1 site (Cluj-Napoca, Romania) |
| Trial ID | NCT06262464 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of a two-week prevention program designed for adults who are at risk of developing Obsessive-Compulsive Disorder (OCD). Participants will be randomly assigned to either the experimental group, which will receive the prevention program consisting of three group sessions per week, or the control group, which will receive treatment as usual (TAU). The study will assess whether the prevention program can significantly reduce OCD symptoms compared to the control group. All participants will be blinded to their group allocation to ensure unbiased results.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over the age of 18 who are at risk of developing OCD but do not currently have a clinical diagnosis.
Not a fit: Patients who are currently diagnosed with OCD or undergoing psychiatric treatment may not benefit from this prevention program.
Why it matters
Potential benefit: If successful, this program could help prevent the onset of OCD in at-risk adults, potentially improving their quality of life.
How similar studies have performed: While there is limited data on similar prevention programs specifically for OCD, the concept of tertiary prevention has shown promise in related mental health fields.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- age over 18 Exclusion Criteria: * clinically diagnosed OCD * current psychiatric/psychotherapeutic treatment * personality disorder diagnosis * suicidal ideation
Where this trial is running
Cluj-Napoca, Romania
- Babes-Bolyai University, Faculty of Psychology and Educational Sciences, Department of Clinical Psychology and Psychotherapy — Cluj-Napoca, Romania, Romania (Recruiting)
Study contacts
- Principal investigator: Roxana Cardoș, PhD — Babeș-Bolyai University
- Study coordinator: Roxana Cardoș, PhD
- Email: roxanaoltean@psychology.ro
- Phone: 0040751477323
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.